Ellevest, Inc. Nkarta, Inc. Transaction History

Ellevest, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 18, 2022	SELL	$7.77 - $19.44 $155 - $388	-20 Reduced 83.33%	4 $0
Q1 2022 Apr 19, 2022	SELL	$8.66 - $14.99 $43 - $74	-5 Reduced 17.24%	24 $0
Q4 2021 Jan 24, 2022	BUY	$12.79 - $26.88 $217 - $456	17 Added 141.67%	29 $0
Q3 2021 Oct 19, 2021	BUY	$26.67 - $38.76 $213 - $310	8 Added 200.0%	12 $0
Q2 2021 Jul 13, 2021	BUY	$23.94 - $36.68 $95 - $146	4 New	4 $0

129

66.5M

173K

20K

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $127M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.